2017 News
-
Information
-
Press Release IR News
Santen Receives Complete Response Letter from U.S. FDA for Intravitreal Sirolimus (DE-109)
-
Press Release IR News
-
Press Release IR News
Santen Announces Approval of Diquas for the Treatment of Dry Eye in China
-
Press Release IR News
Santen Reports the 2nd Quarter Fiscal 2017 Consolidated Performance
-
Press Release
-
Information
-
Press Release IR News
-
Press Release IR News
Notice on Details of Subscription Rights to New Shares(Stock Options for Stock-Linked Remuneration)
-
Press Release IR News
Santen to Grant Subscription Rights to New Shares as Stock Options for Stock-Linked Remuneration
-
Press Release IR News
Santen Reports the 1st Quarter Fiscal 2017 Consolidated Performance
-
Press Release IR News
-
Press Release IR News
-
Press Release
Santen Donates to Northern Kyushu Area Disaster Relief Efforts
-
Information
-
Press Release IR News
-
Press Release IR News
Notice of Board of Director and Corporate Auditor Nominations
-
Press Release
Santen to Establish a Corporate Venture Capital Fund in the United States
-
Press Release IR News
-
Press Release IR News
Santen Announces Strategic Investment in Regenerative Patch Technologies LLC
-
Information
-
Press Release IR News
Santen and Japan Blind Football Association (JBFA) Enter Partnership
-
Press Release IR News
-
Press Release IR News
-
Press Release
-
Information
Voice conference on the Financial Result of the 3rd Quarter of FY2016
-
Press Release IR News
Santen Reports the 3rd Quarter Fiscal 2016 Consolidated Performance
-
Information
Presentation materials for the 35th Annual J.P.Morgan Healthcare Conference